VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_19-vv-01322 Package ID: USCOURTS-cofc-1_19-vv-01322 Petitioner: Leia A. Prause Filed: 2019-08-30 Decided: 2021-11-23 Vaccine: influenza Vaccination date: 2016-09-07 Condition: Guillain-Barre syndrome (GBS) which progressed to chronic inflammatory demyelinating polyneuropathy (CIDP) Outcome: compensated Award amount USD: 225000 AI-assisted case summary: Leia A. Prause filed a petition alleging that an influenza vaccine administered on September 7, 2016, caused her to develop Guillain-Barre syndrome (GBS), which progressed to chronic inflammatory demyelinating polyneuropathy (CIDP) and resulted in residual health problems. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused or aggravated Ms. Prause's GBS and CIDP, and also denied that her condition was a sequela of a vaccine-related injury. The respondent further denied that Ms. Prause sustained a GBS Table injury. Despite these denials, the parties reached a stipulation recommending an award of compensation. The parties agreed that Ms. Prause would receive a lump sum of $225,000.00 as compensation for all damages. The Special Master reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court. Judgment was entered in accordance with the terms of the stipulation, compensating Ms. Prause for her alleged vaccine injury. Theory of causation field: Off-Table Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_19-vv-01322-0 Date issued/filed: 2021-12-20 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 11/23/2021) regarding 62 DECISION Stipulation. Signed by Special Master Nora Beth Dorsey. (mjf) Service on parties made. -------------------------------------------------------------------------------- Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: November 23, 2021 * * * * * * * * * * * * * * * LEIA A. PRAUSE, * UNPUBLISHED * Petitioner, * No. 19-1322V * v. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; Influenza AND HUMAN SERVICES, * (“Flu”) Vaccine; Guillain-Barre * Syndrome (“GBS”); Chronic Inflammatory Respondent. * Demyelinating Polyneuropathy (“CIDP”). * * * * * * * * * * * * * * * * Glen H. Sturtevant, Jr., Rawls Law Group, Richmond, VA, for petitioner. Camille M. Collett, US Department of Justice, Washington, DC, for respondent. DECISION BASED ON STIPULATION1 On August 30, 2019, Leia A. Prause (“petitioner”) filed a petition in the National Vaccine Injury Compensation Program.2 Petitioner alleged that as a result of influenza (“flu”) vaccination on September 7, 2016, she developed Guillain-Barre syndrome (“GBS”) which progressed to chronic inflammatory demyelinating polyneuropathy (“CIDP”) and residual health problems. Petition at 1 (ECF No. 1). On November 23, 2021, the parties filed a stipulation recommending an award of compensation to petitioner. Stipulation (ECF No. 61). Respondent denies that petitioner sustained a GBS Table injury, and further denies that the flu vaccine caused, or significantly 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C. § 300aa. 1 Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 2 of 7 aggravated, petitioner’s GBS and/or CIDP or any other injury; and denies that her current condition is sequela of a vaccine-related injury. Id. at ¶ 6. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that petitioner shall receive the following compensation: (1) A lump sum of $225,000.00 in the form of a check payable to petitioner. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). Stipulation at ¶ 8. The undersigned approves the requested amount for petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Nora Beth Dorsey Nora Beth Dorsey Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 3 of 7 Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 4 of 7 Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 5 of 7 Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 6 of 7 Case 1:19-vv-01322-UNJ Document 68 Filed 12/20/21 Page 7 of 7